A smiling veterinarian in green scrubs hugging a happy dog.

Felixvet:
Shaping the Future of Bioequivalent Generics in Animal Health

We were founded with a clear mission: to redefine the standard for animal health generics through innovation, quality and accessibility.

Built on Science. Driven by Innovation. Focused on Animal Health.

Our growing portfolio includes a diverse range of FDA-approved animal health products, with additional products in development and new approvals anticipated each year. This momentum reflects our deep commitment to science, regulatory excellence and manufacturing capabilities designed specifically for animal health.

Advancing Veterinary Medicine Through Science and Expertise

We operate with a fully integrated model — managing every step from development and regulatory submission through production, packaging and supply chain coordination. This ensures the reliability, consistency and compliance that veterinarians, distributors and pet owners can depend on.

Through continued investment in advanced R&D and innovative delivery technologies, Felixvet is expanding access to trusted therapies across multiple therapeutic categories. From our global network of scientific experts to our dedicated focus in the U.S. market, we’re building a company that’s not just part of the animal health industry’s future — we’re helping define it.

Rooted in Experience. Focused on Innovation.

Felixvet’s U.S. leadership team brings deep experience across animal health, pharmaceuticals and commercialization.

Guided by global expertise and a commitment to scientific progress, we’re building a company that delivers trusted, bioequivalent generics and innovative solutions designed to advance veterinary care.

Neeraj Agrawal
Neeraj Agrawal

COO, Felix Generics Pvt Ltd

A profile photo of Vince Palasota, president of U.S. operations for Felixvet.
Vince Palasota

President, US Operations

A profile photo of Steve Schram, vice president of business development for Felixvet.
Steve Schram

VP, Business Development

A profile photo of Lauren Landolph, vice president and head of commercial and distribution channel for Felixvet.
Lauren Landolph

VP, Head of Commercial & Distribution Channel

A profile photo of Paula Flavin, project marketing manager for U.S. operations for Felixvet.
Paula Flavin

Project Marketing Manager, US Operations

A profile photo of Matthew Maggio, director of corporate accounts for North America for Felixvet.
Matthew Maggio

Director of Corporate Accounts for North America

A profile photo of Michael Morelli, Director of Corporate Accounts for North America for Felixvet.
Michael Morelli

Director of Corporate Accounts for North America

A profile photo of Doug Shane, MD and veterinary director for Felixvet.
Dr. Doug Shane, DVM

Veterinary Director

News

A white 'FDA APPROVED' seal logo overlaid on a blue-tinted background.
Felixvet Receives FDA Approval for Cefpodoxime Proxetil Tablets
Felixvet Receives FDA Approval for Cefpodoxime Proxetil Tablets

Felixvet earns FDA approval for Cefpodoxime Proxetil Tablets, an antimicrobial indicated for the treatment of skin infections in...

Read Article
A white 'FDA APPROVED' seal logo overlaid on a blue-tinted background.
Felixvet Receives FDA Approval for Clindamycin Hydrochloride Tablets
Felixvet Receives FDA Approval for Clindamycin Hydrochloride Tablets

Felixvet has secured FDA approval for Clindamycin Hydrochloride Tablets to treat bacterial infections in dogs. Learn more about...

Read Article
The logo for Felixvet in large white font overlaid on a soft, orange-tinted, blurred background showing a person holding a corgi dog.
Felixvet Unveils Feline Hyperthyroidism Drug
Felixvet Unveils Feline Hyperthyroidism Drug

As announced by the FDA

Read Article